<p>Researcher from Federation of American Societies for Experimental Biology recently unlocked a concept over obesity control, the basic concept involves by combining concept of stem cell therapy and genetic engineering may help in developing cells having desired functions.</p><p>The concern research recently appears in March 2016 issue of The FASEB Journal; the result of experiment may help in one-day manipulate the type or quantity of fat cells created to ultimately reduce the risk of diseases impacted by the prevalence of unhealthy fat, such as cardiovascular disease, types 2 diabetes, high blood pressure, sleep apnea, asthma, pulmonary hypertension, gall bladder disease, kidney disease, some cancers, as well as obesity too.<br /><br /><img src="http://www.microbiozindia.com/images/ADERTY.png" alt="" /></p><h2>According to scientist,</h2><p>&amp;quot;Our study suggests that it may be the type of fat-storing cells produced in our bodies that determines risk for disease, rather than the amount of fat,&amp;quot; said Dwight J. Klemm, Ph.D., a researcher involved in the work from the University of Colorado Anschutz Medical Campus in Aurora, Colorado. &amp;quot;This paradigm highlights the possibility of new strategies to prevent and reverse fat-related chronic disease by controlling the production of different types of fat-storing cells.&amp;quot;</p><p>Note: The above story is for information purposes only for more information go through original story source.</p><p>Journal References</p><p>K. M. Gavin, J. A. Gutman, W. M. Kohrt, Q. Wei, K. L. Shea, H. L. Miller, T. M. Sullivan, P. F. Erickson, K. M. Helm, A. S. Acosta, C. R. Childs, E. Musselwhite, M. Varella-Garcia, K. Kelly, S. M. Majka, D. J. Klemm. De novo generation of adipocytes from circulating progenitor cells in mouse and human adipose tissue. The FASEB Journal, 2015; 30 (3): 1096 DOI: 10.1096/fj.15-27899</p>